RESUMO
The review embraces major trends and tendencies in liposome studies and is based on the statistical and qualitative analysis of patent information issued in the period 1970-1988. Special attention is devoted to the analysis of patents in liposome production techniques, their lipid composition, and application in pharmaceutical and cosmetic industries and also for the diagnostic and therapeutic purposes. Liposomal preparations are shown to be superior to common drugs as concerns, in particular, liposomes containing medicinal agents for prolonged use (including hormones, antibiotics, cytostatics, and immunostimulants) and liposomes used in dermatological practice. Liposome-based assessment of application prospects is given.
Assuntos
Tratamento Farmacológico/métodos , Saúde Global , Pesquisa sobre Serviços de Saúde/tendências , Lipossomos , Patentes como Assunto , Preparações Farmacêuticas/administração & dosagem , Portadores de Fármacos , Humanos , Lipossomos/síntese química , Lipossomos/uso terapêutico , Tecnologia Farmacêutica/métodosRESUMO
Encapsulation and electron microscopy studies have shown that aqueous dispersions of several nonionic emulsifiers with sucrosepalmitatestearate (SPS) structure and cholesterol (Chol) result in synthetic lipid vesicles. This was demonstrated for the commercial emulsifier sucrosepalmitatestearate for the first time. Such vesicles were able to entrap aqueous solutes, for instance the fluorescence marker carboxyfluorescein (CF) for a period of more than 10 weeks with latencies of about 90 per cent. Though SPS/Chol-vesicles tended to flocculate--especially in concentrated solutions--the efflux of entrapped solutes after storage was lower in these vesicles compared with liposomes consisting of natural egg phosphatidylcholine (EPC) and cholesterol.